Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?
暂无分享,去创建一个
P. Krack | E. Moro | V. Fraix | F. Durif | E. Broussolle | S. Thobois | J. Azulay | M. Anheim | A. Castrioto | C. Tranchant | A. Maillet | E. Lhommée | H. Klinger | I. Bénatru | E. Schmitt | A. Bichon | P. Pélissier | M. Béreau | A. Gerazime | N. Longato | I. Benatru | P. Pelissier
[1] M. Apps,et al. Motivational fatigue: A neurocognitive framework for the impact of effortful exertion on subsequent motivation , 2019, Neuropsychologia.
[2] J. Dalley,et al. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease? , 2016, Front. Psychiatry.
[3] J. Groothoff,et al. The associations between fatigue, apathy, and depression in Parkinson's disease , 2015, Acta neurologica Scandinavica.
[4] Ting Yu,et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.
[5] Joong-Seok Kim,et al. The Dysfunctional Autonomic Function and "Dysfunctional" Fatigue in Drug Naïve Parkinson's Disease. , 2020, Journal of Parkinson's disease.
[6] H. Tachibana,et al. Clinical correlates of anhedonia in patients with Parkinson's disease , 2013, Clinical Neurology and Neurosurgery.
[7] C. Chiorri,et al. Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study. , 2020, Parkinsonism & related disorders.
[8] A. Berardelli,et al. Relationship between pain and motor and non‐motor symptoms in Parkinson's disease , 2017, European journal of neurology.
[9] Paul Krack,et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. , 2013, Brain : a journal of neurology.
[10] L. Uddin. Salience processing and insular cortical function and dysfunction , 2014, Nature Reviews Neuroscience.
[11] A. Tessitore,et al. Fatigue in Parkinson's disease: A systematic review and meta‐analysis , 2018, Movement disorders : official journal of the Movement Disorder Society.
[12] Roger M Enoka,et al. Fatigue and fatigability in neurologic illnesses , 2013, Neurology.
[13] S. Wessely,et al. The Parkinson fatigue scale , 2005 .
[14] F. Esposito,et al. Functional connectivity underpinnings of fatigue in “Drug‐Naïve” patients with Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.
[15] Clay B. Holroyd,et al. Brain mechanisms underlying apathy , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[16] A. Der-Avakian,et al. The neurobiology of anhedonia and other reward-related deficits , 2012, Trends in Neurosciences.
[17] P. Krystkowiak,et al. Anhedonia in Parkinson's disease: an overview. , 2012, The Journal of neuropsychiatry and clinical neurosciences.
[18] D. Brooks,et al. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. , 2010, Brain : a journal of neurology.
[19] L. Tremblay,et al. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease. , 2016, Brain : a journal of neurology.
[20] T. McMorris,et al. Central fatigue theory and endurance exercise: Toward an interoceptive model , 2018, Neuroscience & Biobehavioral Reviews.
[21] J. Friedman,et al. Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. , 2013, Parkinsonism & related disorders.
[22] A. Tessitore,et al. Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients. , 2017, Parkinsonism & related disorders.
[23] S. Albert,et al. Triggers and alleviating factors for fatigue in Parkinson’s disease , 2021, PloS one.
[24] K. Dujardin,et al. International validation of a behavioral scale in Parkinson's disease without dementia , 2015, Movement disorders : official journal of the Movement Disorder Society.
[25] P. Krack,et al. A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD , 2020, npj Parkinson's Disease.
[26] F. Fazekas,et al. The Mattis Dementia Rating Scale , 1994, Neurology.
[27] K. Walters,et al. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study , 2015, The Lancet Neurology.
[28] K. Dujardin,et al. Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review , 2020, Movement disorders : official journal of the Movement Disorder Society.
[29] I Litvan,et al. The FAB: A frontal assessment battery at bedside , 2000, Neurology.
[30] K. Chaudhuri,et al. Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice , 2020, Expert review of neurotherapeutics.
[31] W. Poewe,et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[32] L. Tremblay,et al. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.
[33] A. Tessitore,et al. Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue , 2020, Journal of Neural Transmission.
[34] A. Tessitore,et al. Prevalence of fatigue in Parkinson disease and its clinical correlates , 2014, Neurology.
[35] J. Roiser,et al. Neuroscience of apathy and anhedonia: a transdiagnostic approach , 2018, Nature Reviews Neuroscience.
[36] L. Tremblay,et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.
[37] R. Fitzpatrick,et al. PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures , 1998, Journal of Neurology.
[38] F. Paul,et al. Fatigue as a symptom or comorbidity of neurological diseases , 2017, Nature Reviews Neurology.
[39] J. Friedman,et al. Fatigue in levodopa-naïve subjects with Parkinson disease , 2008, Neurology.
[40] P. Krystkowiak,et al. Hedonic Deficits in Parkinson’s Disease: Is Consummatory Anhedonia Specific? , 2014, Front. Neurol..
[41] Y. Kim,et al. Fatigue in Drug-Naïve Parkinson's Disease , 2013, European Neurology.
[42] E. Tolosa,et al. The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) , 2015, Movement disorders : official journal of the Movement Disorder Society.
[43] J. Jankovic,et al. Variable expression of Parkinson's disease , 1990, Neurology.
[44] S. Houle,et al. Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes , 2017, Human brain mapping.
[45] P. Hagell,et al. Towards an understanding of fatigue in Parkinson disease , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[46] A. Chaudhuri,et al. Fatigue in neurological disorders , 2004, The Lancet.
[47] L. Defebvre,et al. Apathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.
[48] A. Strafella,et al. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment , 2015, The Lancet Neurology.
[49] A. Chaudhuri,et al. Fatigue and basal ganglia , 2000, Journal of the Neurological Sciences.
[50] J. Larsen,et al. Fatigue in early Parkinson's disease: the Norwegian ParkWest study , 2017, European journal of neurology.
[51] J. Lou,et al. Parkinson's disease‐related fatigue: A case definition and recommendations for clinical research , 2016, Movement disorders : official journal of the Movement Disorder Society.